GB0720136D0 - Treatment of blood disorded - Google Patents

Treatment of blood disorded

Info

Publication number
GB0720136D0
GB0720136D0 GBGB0720136.1A GB0720136A GB0720136D0 GB 0720136 D0 GB0720136 D0 GB 0720136D0 GB 0720136 A GB0720136 A GB 0720136A GB 0720136 D0 GB0720136 D0 GB 0720136D0
Authority
GB
United Kingdom
Prior art keywords
disorded
blood
treatment
blood disorded
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0720136.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto Superiore di Sanita ISS
Original Assignee
Istituto Superiore di Sanita ISS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Superiore di Sanita ISS filed Critical Istituto Superiore di Sanita ISS
Priority to GBGB0720136.1A priority Critical patent/GB0720136D0/en
Publication of GB0720136D0 publication Critical patent/GB0720136D0/en
Priority to PCT/EP2008/008989 priority patent/WO2009049917A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0720136.1A 2007-10-15 2007-10-15 Treatment of blood disorded Ceased GB0720136D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0720136.1A GB0720136D0 (en) 2007-10-15 2007-10-15 Treatment of blood disorded
PCT/EP2008/008989 WO2009049917A1 (en) 2007-10-15 2008-10-15 Kit ligand for use in the treatment of beta-thalassaemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0720136.1A GB0720136D0 (en) 2007-10-15 2007-10-15 Treatment of blood disorded

Publications (1)

Publication Number Publication Date
GB0720136D0 true GB0720136D0 (en) 2007-11-28

Family

ID=38813843

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0720136.1A Ceased GB0720136D0 (en) 2007-10-15 2007-10-15 Treatment of blood disorded

Country Status (2)

Country Link
GB (1) GB0720136D0 (en)
WO (1) WO2009049917A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011000A (en) * 1995-03-03 2000-01-04 Perrine; Susan P. Compositions for the treatment of blood disorders

Also Published As

Publication number Publication date
WO2009049917A1 (en) 2009-04-23

Similar Documents

Publication Publication Date Title
HK1207578A1 (en) Treatment of synucleinopathies
GB0610867D0 (en) Treatment of pain
HUS1600057I1 (en) Methods of treatment using ammonia-scavenging drugs
EP2129369A4 (en) Treatment of adhd
IL193748A0 (en) Treatment of pain
IL208354A0 (en) Methods of treatment
EP2155225A4 (en) Methods of treatment of skin ulcers
ZA200806808B (en) Treatment of stressed patients
HRP20181877T1 (en) Methods of treatment using ammonia-scavenging drugs
IL213703A (en) Compounds for the treatment of pain and other diseases
ZA201000225B (en) Treatment of depression
GB0610868D0 (en) Treatment of pain
GB0723100D0 (en) Treatment of HFnEF
EP2164494A4 (en) Methods of treatment
GB0616450D0 (en) Treatment of pain
GB0623740D0 (en) Treatment of disease
GB0720136D0 (en) Treatment of blood disorded
EP2203432A4 (en) Method of treatment
AU2016202705A1 (en) Treatment of synucleinopathies
GB0700886D0 (en) Medical treatment
GB0700969D0 (en) Methods of treatment
GB0819543D0 (en) Treatment of proteostatic disease
GB0817859D0 (en) Treatment of proteostatic disease
GB0600817D0 (en) Medical treatment
GB0625602D0 (en) Treatment of sialorrhoea

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)